Concepedia

Xuejing Wang

XW

37

Publications

1.6K

Citations

22

H-Index

2009

Active since

Affiliations

Eli Lilly (United States)(Current)

Peking University

Peking University First Hospital

Peking Union Medical College Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Xuejing Wang is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and oncology.

ORCID

Top concepts

Publications per year

2009–2023

37

Publications

37

Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer

Dan Li, Yulan Zhao, Changxing Liu et al. · Clinical Cancer Research · 2011 · 337 citations · Full text

Assessment of heavy metals in some wild edible mushrooms collected from Yunnan Province, China

Fangkun Zhu, Li Qu, Wenxiu Fan et al. · Environmental Monitoring and Assessment · 2010 · 164 citations

, , +12

MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF

Chao Zou, Qing Xu, Feng Mao et al. · Cell Cycle · 2012 · 136 citations · Full text

, , +14

A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia

Saroj Vadhan‐Raj, Rafat Abonour, Jonathan W. Goldman et al. · Journal of Hematology & Oncology · 2017 · 83 citations · Full text

An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia

David A. Rizzieri, Sarah Cooley, Olatoyosi Odenike et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 74 citations

Rows per page

1–5 of 37